Bull Math Biol 2004, 66:523–537.CrossRefPubMed 37. Hybiske K, Stephens RS: Mechanisms AZD4547 clinical trial of host cell exit
by the intracellular bacterium Chlamydia. Proc Natl Acad Sci USA 2007, 104:11430–11435.CrossRefPubMed 38. Raulston JE: Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun 1997, 65:4539–4547.PubMed 39. Bailey L, Gylfe A, Sundin C, Muschiol S, Elofsson M, Nordstrom P, Henriques-Normark B, Lugert R, Waldenstrom A, Wolf-Watz H, Bergstrom S: Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett 2007, 581:587–595.CrossRefPubMed 40. Shivshankar P, Lei
L, Wang J, Zhong G: Rottlerin inhibits chlamydial intracellular growth and blocks chlamydial acquisition of sphingolipids from host cells. Appl Environ Microbiol 2008, 74:1243–1249.CrossRefPubMed 41. Wolf Caspase-independent apoptosis K, Betts HJ, Chellas-Gery B, Hower S, selleck chemicals llc Linton CN, Fields KA: Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol Microbiol 2006, 61:1543–1555.CrossRefPubMed 42. Yan Y, Silvennoinen-Kassinen S, Tormakangas L, Leinonen M, Saikku P: Selective cyclooxygenase inhibitors prevent the growth of Chlamydia pneumoniae in HL cells. Int J Antimicrob Agents 2008, 32:78–83.CrossRefPubMed 43. Coombes BK, Mahony JB: Identification of MEK- and phosphoinositide 3-kinase-dependent signalling as essential events during Chlamydia pneumoniae invasion of HEp2 cells. Cell Microbiol 2002, 4:447–460.CrossRefPubMed 44. Muschiol S, Bailey L, Gylfe A, Sundin C, Hultenby K, Bergstrom S, Elofsson M, Wolf-Watz H, Normark S, Henriques-Normark B: A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci USA 2006, 103:14566–14571.CrossRefPubMed 45. Johnson DL, Mahony JB:Chlamydophila pneumoniae PknD exhibits dual amino acid
specificity and phosphorylates Cpn0712, a putative type III secretion YscD homolog. J Bacteriol 2007, 189:7549–7555.CrossRefPubMed CHIR-99021 ic50 46. Mahony JB, Johnson DL, Coombes BK, Song X: Expression of a Novel Protein Kinase Gene (Cpn0148) During the Replication Cycle of Chlamydia pneumoniae. Chlamydial Infections, International Symposium on Human Chlamydial Infections (Edited by: Schachter J, Christiansen G, Clarke I). Antalya, Turkey. International Chlamydia Symposium, San Francisco, CA 2002, 10:559–562. 47. Stone CB, Johnson DL, Bulir DC, Gilchrist JD, Mahony JB: Characterization of the putative type III secretion ATPase CdsN (Cpn0707) of Chlamydophila pneumoniae. J Bacteriol 2008, 190:6580–6588.CrossRefPubMed 48.